3D-FAA63168 - 3-24-dihydroxyphenylpropionic-acid
3-(3,4-Dihydroxyphenyl)propanoic acid
CAS :Formule :C9H10O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :182.17332,3-Dihydroxy-benzenepropanoic acid
CAS :Formule :C9H10O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :182.17333,3,3-trideuterio-2-[dideuterio-(3,4-dihydroxyphenyl)methyl]-2-hydrazinylpropanoic acid
CAS :Formule :C10H14N2O4Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :226.2292(2RS)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic Acid (rac-Carbidopa)
CAS :Couleur et forme :NeatTolfenpyrad
CAS :Produit contrôléStability Hygroscopic
Applications An inhibitor of aromatic amino acid decarboxylase.
References Sletzinger, M., et al.: J. Med. Chem., 6, 101 (1963)Formule :C10H14N2O4Couleur et forme :Light YellowMasse moléculaire :226.23(S)-(-)-Carbidopa
CAS :Produit contrôléStability Unstable in Solution
Applications (S)-(-)-Carbidopa is a peripheral decarboxylase inhibitor that is commonly used in combination with L-DOPA (D533751) for treatment of Parkinsonism. S(-)-Carbidopa ( has also been shown to prolong the elimination half-life of L-DOPA from blood plasma and skeletal muscle.
References Henry, G.M. et al.: Psychosom. Med., 38, 95 (1976); Leguire, L.E. et al.: Invest. Ophthalmol. Vis. Sci. 34, 3090 (1993); Deleu, D. et al.: Naun. Schmied. Arch. Pharmacol. 348: 576 (1993);Formule :C10H14N2O4Couleur et forme :NeatMasse moléculaire :226.23Des-hydrazino Carbidopa
CAS :Applications A metabolite of Carbidopa (C175915).
References Vickers, S., et al.: Drug Metab. Dispos., 2, 6 (1974), Vickers, S., et al.: J. Med. Chem., 18, 134 (1975),Formule :C10H12O4Couleur et forme :NeatMasse moléculaire :196.23-(3,4-Dihydroxyphenyl)-2-methylpropanoic acid
CAS :3-(3,4-Dihydroxyphenyl)-2-methylpropanoic acid
Degré de pureté :98%2-Methyl-3-(3,4-dihydroxyphenyl)propanoic acid
CAS :2-Methyl-3-(3,4-dihydroxyphenyl)propanoic acid (DOPA) is a prodrug that is converted to the active form 2-methyl-5,6-dihydroxyindole-3,4-dione (DIDO) by hydrazine. DIDO inhibits melanoma cells by binding to tyrosinase and inhibiting its activity. DOPA also has cytotoxic properties, which may be due to the production of oxidative metabolites such as hydrogen peroxide and free radicals. DIDO can also be metabolized into catechol and cyclized into quinone methides. DOPA can inhibit oxidation reactions in the cell line CCRF-CEM by preventing the oxidation of NADH to NAD+.Formule :C10H12O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :196.2 g/molCarbidopa Monohydrate
CAS :Formule :C10H14N2O4·H2ODegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalineMasse moléculaire :244.253-(2,4-Dihydroxyphenyl)propanoic acid
CAS :Formule :C9H10O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :182.1733rac-Carbidopa-13C-d3
CAS :Formule :C913CH11D3N2O4Couleur et forme :White To Off-White SolidMasse moléculaire :230.24Carbidopa
CAS :Formule :C10H14N2O4Couleur et forme :White To Off-White SolidMasse moléculaire :226.233-(2,4-Dihydroxyphenyl)propanoic acid
CAS :3-(2,4-Dihydroxyphenyl)propanoic acidDegré de pureté :≥98%Masse moléculaire :182.17g/mol(S)-3-(3,4-Dihydroxyphenyl)-2-Hydrazinyl-2-Methylpropanoic Acid
CAS :(S)-3-(3,4-Dihydroxyphenyl)-2-Hydrazinyl-2-Methylpropanoic AcidDegré de pureté :97%Masse moléculaire :226.23g/mol3-(2,4-Dihydroxyphenyl)Propionic Acid
CAS :3-(2,4-Dihydroxyphenyl)Propionic AcidDegré de pureté :97%Masse moléculaire :182.17g/mol3-(2,4-Dihydroxyphenyl)propionic acid
CAS :Formule :C9H10O4Degré de pureté :95%~99%Couleur et forme :PowderMasse moléculaire :182.175
![3,3,3-trideuterio-2-[dideuterio-(3,4-dihydroxyphenyl)methyl]-2-hydrazinylpropanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I5DW.webp&w=3840&q=75)
